Free Trial
NASDAQ:STIM

Neuronetics (STIM) Stock Price, News & Analysis

Neuronetics logo
$3.40 -0.02 (-0.44%)
Closing price 07/3/2025 01:40 PM Eastern
Extended Trading
$3.40 0.00 (0.00%)
As of 07/3/2025 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Neuronetics Stock (NASDAQ:STIM)

Key Stats

Today's Range
$3.36
$3.45
50-Day Range
$3.38
$4.67
52-Week Range
$0.52
$5.92
Volume
441,141 shs
Average Volume
816,416 shs
Market Capitalization
$224.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Moderate Buy

Company Overview

Neuronetics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

STIM MarketRank™: 

Neuronetics scored higher than 33% of companies evaluated by MarketBeat, and ranked 2110th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Neuronetics has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Neuronetics has received no research coverage in the past 90 days.

  • Read more about Neuronetics' stock forecast and price target.
  • Earnings Growth

    Earnings for Neuronetics are expected to grow in the coming year, from ($1.13) to ($0.82) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Neuronetics is -2.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Neuronetics is -2.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Neuronetics has a P/B Ratio of 5.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Neuronetics' valuation and earnings.
  • Percentage of Shares Shorted

    5.18% of the float of Neuronetics has been sold short.
  • Short Interest Ratio / Days to Cover

    Neuronetics has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Neuronetics has recently increased by 13.92%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Neuronetics does not currently pay a dividend.

  • Dividend Growth

    Neuronetics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.18% of the float of Neuronetics has been sold short.
  • Short Interest Ratio / Days to Cover

    Neuronetics has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Neuronetics has recently increased by 13.92%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 2 people have searched for STIM on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Neuronetics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Neuronetics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $826,074.00 in company stock.

  • Percentage Held by Insiders

    Only 8.70% of the stock of Neuronetics is held by insiders.

  • Percentage Held by Institutions

    53.59% of the stock of Neuronetics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Neuronetics' insider trading history.
Receive STIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neuronetics and its competitors with MarketBeat's FREE daily newsletter.

STIM Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

STIM Stock Analysis - Frequently Asked Questions

Neuronetics' stock was trading at $1.61 at the start of the year. Since then, STIM stock has increased by 111.5% and is now trading at $3.4050.

Neuronetics, Inc. (NASDAQ:STIM) announced its earnings results on Tuesday, May, 6th. The company reported ($0.21) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.08. The business earned $31.98 million during the quarter, compared to analysts' expectations of $29.07 million. Neuronetics had a negative trailing twelve-month return on equity of 174.15% and a negative net margin of 53.67%.
Read the conference call transcript
.

Neuronetics (STIM) raised $75 million in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. Piper Jaffray and William Blair served as the underwriters for the IPO and Canaccord Genuity, BTIG and JMP Securities were co-managers.

Shares of STIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neuronetics investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Pfizer (PFE), GE Aerospace (GE), Intel (INTC), Bank of America (BAC) and Nokia (NOK).

Company Calendar

Last Earnings
5/06/2025
Today
7/04/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:STIM
Employees
180
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.50
High Stock Price Target
$8.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+61.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$43.71 million
Pretax Margin
-54.27%

Debt

Sales & Book Value

Annual Sales
$74.89 million
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
5.97

Miscellaneous

Free Float
60,094,000
Market Cap
$224.12 million
Optionable
Optionable
Beta
1.85
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:STIM) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners